CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
Parkinson’s disease (PD) affects millions of patients worldwide and is characterized by alpha-synuclein aggregation in dopamine neurons. Molecular tweezers have shown high potential as anti-aggregation agents targeting positively charged residues of proteins undergoing amyloidogenic processes. Here...
Main Authors: | Bengoa-Vergniory, N, Faggiani, E, Ramos-Gonzalez, P, Kirkiz, E, Connor-Robson, N, Brown, L, Siddique, I, Li, Z, Vingill, S, Cioroch, M, Cavaliere, F, Threlfell, S, Roberts, B, Schrader, T, Klärner, F-G, Cragg, S, Gal Bitan, Dehay, B, Matute, C, Bezard, E, Wade-Martins, R |
---|---|
Format: | Journal article |
Jezik: | English |
Izdano: |
Springer Nature
2020
|
Podobne knjige/članki
-
CLR01 protects dopaminergic neurons in vitro and in mouse models of Parkinson’s disease
od: Nora Bengoa-Vergniory, et al.
Izdano: (2020-09-01) -
Impairment of macroautophagy in dopamine neurons has opposing effects on parkinsonian pathology and behaviour
od: Hunn, B, et al.
Izdano: (2019) -
REST protects dopaminergic neurons from mitochondrial and α-synuclein oligomer pathology in an alpha synuclein overexpressing BAC-transgenic mouse model
od: Ryan, BJ, et al.
Izdano: (2021) -
The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
od: Jing Di, et al.
Izdano: (2021-01-01) -
Correction to: The molecular tweezer CLR01 improves behavioral deficits and reduces tau pathology in P301S-tau transgenic mice
od: Jing Di, et al.
Izdano: (2021-04-01)